Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Cochet

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
The Biochemical Journal|August 24, 2007
Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interactionBéatrice Laudet, Caroline Barette, Vincent Dulery, et al.
Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of ActionBenoît Bestgen, Irina Kufareva, Weiguang Seetoh, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarraysSophie Giusiano, Claude Cochet, Odile Filhol, et al.
Journal of Leukocyte Biology|October 7, 2016
Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizersMarie de Bourayne, Yann Gallais, Zeina El Ali, et al.
Chemistry & Biology|July 19, 2008
Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2Renaud Prudent, Virginie Moucadel, Béatrice Laudet, et al.
European Journal of Medicinal Chemistry|November 20, 2024
Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffoldHend Khalifa, Ahmed K ElHady, Ting Liu, et al.
Molecular and Cellular Biochemistry|May 15, 2020
CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteomeYasser Perera, Yassel Ramos, Gabriel Padrón, et al.
Cell Death Discovery|February 27, 2026
Using 3D Invasion properties of RCC Cell Lines In Vitro to predict their Metastatic Potential In VivoBeatrice Cesana, Laurie Nemoz-Billet, Valentin Azemard, et al.
Cell Death & Disease|September 22, 2023
A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell CarcinomaIrinka Séraudie, Catherine Pillet, Beatrice Cesana, et al.
Cancers|January 23, 2020
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal CarcinomaCaroline Roelants, Catherine Pillet, Quentin Franquet, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Biochemical Journal|August 24, 2007
Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interactionBéatrice Laudet, Caroline Barette, Vincent Dulery, et al.
Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of ActionBenoît Bestgen, Irina Kufareva, Weiguang Seetoh, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarraysSophie Giusiano, Claude Cochet, Odile Filhol, et al.
Journal of Leukocyte Biology|October 7, 2016
Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizersMarie de Bourayne, Yann Gallais, Zeina El Ali, et al.
Chemistry & Biology|July 19, 2008
Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2Renaud Prudent, Virginie Moucadel, Béatrice Laudet, et al.
European Journal of Medicinal Chemistry|November 20, 2024
Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffoldHend Khalifa, Ahmed K ElHady, Ting Liu, et al.
Molecular and Cellular Biochemistry|May 15, 2020
CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteomeYasser Perera, Yassel Ramos, Gabriel Padrón, et al.
Cell Death Discovery|February 27, 2026
Using 3D Invasion properties of RCC Cell Lines In Vitro to predict their Metastatic Potential In VivoBeatrice Cesana, Laurie Nemoz-Billet, Valentin Azemard, et al.
Cell Death & Disease|September 22, 2023
A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell CarcinomaIrinka Séraudie, Catherine Pillet, Beatrice Cesana, et al.
Cancers|January 23, 2020
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal CarcinomaCaroline Roelants, Catherine Pillet, Quentin Franquet, et al.
Pageof 7